Machine learning to predict post-therapy dosimetry for 177Lu-PSMA I&T treatment

被引：0
作者：
Shi, K. [1 ]
Xue, S. [1 ]
Gafita, A. [2 ]
Dong, C. [2 ]
Zhao, Y. [2 ]
Tetteh, G. [2 ]
Menze, B. H. [2 ]
Afshar-Oromieh, A. [1 ]
Eiber, M. [2 ]
Rominger, A. [1 ]
机构：
[1] Univ Bern, Bern, Switzerland
[2] Tech Univ Munich, Munich, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2019年 / 46卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-441
引用
收藏
页码：S170 / S170
页数：1
相关论文
共 50 条
[31]   Comparative Preclinical Biodistribution, Dosimetry, and Endoradiotherapy in Metastatic Castration-Resistant Prostate Cancer Using 19F/177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T [J].
Yusufi, Nahid ;
Wurzer, Alexander ;
Herz, Michael ;
D'Alessandria, Calogero ;
Feuerecker, Benedikt ;
Weber, Wolfgang ;
Wester, Hans-Juergen ;
Nekolla, Stephan ;
Eiber, Matthias .
JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (08) :1106-1111
[32]   PSMA avidity-based recurrent patterns after 177Lu-PSMA I&T in metastatic castration-resistant prostate cancer [J].
Kwon, S. ;
Rauscher, I. ;
D'Alessandria, C. ;
Eiber, M. ;
Weber, W. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) :S655-S655
[33]   Radioligand Therapy with [177Lu]Lu-PSMA I&T in the Elderly - Safety, Efficacy and Prognosticators of Survival [J].
Weber, S. ;
Seitz, A. ;
Kuebler, H. ;
Buck, A. K. ;
Werner, R. A. ;
Hartrampf, P. E. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) :S151-S151
[34]   Estimating 177Lu-PSMA Radiopharmaceutical Therapy Tumor Dosimetry from PET: Implications for Improving Treatment Response [J].
Hesterman, Jacob ;
Orcutt, Kelly ;
Hoppin, Jack ;
Kuo, Phillip .
JOURNAL OF NUCLEAR MEDICINE, 2023, 64
[35]   Dose Calculations and Dose-Effect Relationships in 177Lu-PSMA I&T Radionuclide Therapy for Metastatic Castration-Resistant Prostate Cancer [J].
Barna, Sandra ;
Haug, Alexander R. ;
Hartenbach, Markus ;
Rasul, Sazan ;
Grubmueller, Bernhard ;
Kramer, Gero ;
Blaickner, Matthias .
CLINICAL NUCLEAR MEDICINE, 2020, 45 (09) :661-667
[36]   PSMA Radioligand Therapy of Metastasized Prostate Cancer Using Lu-177 PSMA I&T and Lu-177 PSMA-617: First comparative Dosimetric Results [J].
Schuchardt, C. ;
Kulkarni, H. R. ;
Wiessalla, S. ;
Shahinfar, M. ;
Singh, A. ;
Baum, R. P. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 :S36-S37
[37]   Pre- or Post-Chemotherapy: Effect of 177Lu-PSMA Radioligand Therapy on PSMA Expression [J].
Yadav, Surekha ;
Heath, Courtney Lawhn ;
Juarez, Roxanna ;
De Kouchkovsky, Ivan ;
Aggarwal, Rahul ;
Hope, Thomas .
JOURNAL OF NUCLEAR MEDICINE, 2024, 65
[38]   Simplified Organ and Tumor Dosimetry for Lu-177-PSMA-I&T Radionuclide Therapy [J].
Lehnert, W. ;
Schatz, L. ;
Karimzadeh, A. ;
Apostolova, I. ;
Buchert, R. ;
Klutmann, S. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) :S745-S746
[39]   The use of molecular volumetric parameters for the evaluation of Lu-177 PSMA I&T therapy response and survival [J].
Acar, Emine ;
Ozdogan, Ozhan ;
Aksu, Aysegul ;
Derebek, Erkan ;
Bekis, Recep ;
Kaya, Gamze Capa .
ANNALS OF NUCLEAR MEDICINE, 2019, 33 (09) :681-688
[40]   Impact of the Reference Multiple-Time-Point Dosimetry Protocol on the Validity of Single-Time-Point Dosimetry for [177Lu]Lu-PSMA-I&T 177 Lu]Lu-PSMA-I&T Therapy [J].
Resch, Sandra ;
Ziegler, Sibylle I. ;
Sheikh, Gabriel ;
Unterrainer, Lena M. ;
Zacherl, Mathias J. ;
Bartenstein, Peter ;
Boening, Guido ;
Brosch-Lenz, Julia ;
Delker, Astrid .
JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (08) :1272-1278
12345